Skin Barrier Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The skin barrier market size has grown strongly in recent years. It will grow from $1.12 billion in 2024 to $1.18 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to rising incidence of skin disorders, growing aging population, increased awareness of skin health, changing lifestyle patterns, clinical recommendations and dermatologist endorsements, preference for non-invasive skincare solutions.

The skin barrier market size is expected to see steady growth in the next few years. It will grow to $1.33 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to continued increase in skin disorders, focus on natural and sustainable skincare, globalization of skincare trends, evolving consumer preferences, health and wellness influences. Major trends in the forecast period include development of advanced microbiome-friendly formulations, customized barrier repair solutions, incorporation of probiotics and prebiotics, technological innovations in application methods.

The anticipated growth in the skin barrier market is expected to be driven by factors such as the increasing incidence of autoimmune skin diseases and the growing number of ostomy surgeries worldwide. Autoimmune skin diseases, including conditions such as psoriasis, eczema, and dermatitis, are on the rise, leading to a higher demand for advanced skincare solutions such as skin barriers. For instance, data from the National Psoriasis Foundation in December 2022 reported over 8 million cases of psoriasis in the United States, marking an increase from 7.5 million in the previous year (2021). This trend reflects the growing prevalence of autoimmune skin diseases and contributes to the expansion of the skin barrier market.

The increasing number of ostomy surgeries globally is expected to fuel market growth. Ostomy surgeries involve creating an opening in the abdomen to reroute body waste, either temporarily or permanently, to treat various diseases of the urinary or digestive systems. These surgeries require the use of a skin barrier, which attaches the ostomy pouch to the abdomen, serving to protect the skin from stomal output and prevent damage to peristomal skin. The American Society of Colon and Rectal Surgeons estimates that there are between 750,000 and 1 million ostomates in the United States, with approximately 150,000 individuals undergoing ostomy surgeries annually. Common morbidities associated with ostomy surgeries include parastomal hernia (PSH) and peristomal skin problems, emphasizing the importance of skin barrier products in managing these conditions. The increasing number of ostomy surgeries worldwide is a key driver for the growth of the skin barrier market.

The skin barrier market is expected to face growth constraints due to a shortage of trained professionals. The scarcity of healthcare staff may impede access to care for individuals with skin barrier issues, resulting in extended wait times for patients and delayed treatment, further harming the skin barrier. In December 2021, the American Academy of Dermatology projected a potential shortage of 37,800 to 124,000 physicians in the United States by 2034, with specialties such as dermatology facing a deficiency of 3,800 to 13,400 physicians. This shortage of skilled professionals is currently limiting the expansion of the skin barrier market.

Companies in the skin barrier market are increasingly focusing on introducing products that utilize whole-cell enzyme technology. This technique involves using intact living cells as hosts for producing desired enzymes, with the enzymes not being isolated and purified. For instance, in August 2023, Nikko Chemicals Co. Ltd., a Japanese chemical manufacturing company, launched Nikkol Lecinol MFL, a skin barrier reinforcer enabled by whole-cell enzyme technology. This product enhances the skin's barrier function by promoting keratinization in epidermal cells, stimulating the production of filaggrin and ceramide. The enzymatic reaction in this technology directly involves the use of the enzyme culture solution or its solid component as the biocatalyst.

In September 2022, Arcutis Biotherapeutics Inc., a US-based biopharmaceutical company, acquired Ducentis BioTherapeutics for $30 million. Through this acquisition, Arcutis plans to utilize its dermatology expertise to accelerate the development of Ducentis' lead compound, DS-234, which targets atopic dermatitis and addresses critical unmet needs in the market. Ducentis BioTherapeutics is a UK-based biotech firm specializing in skin barrier products.

Major companies operating in the skin barrier market report are 3M Corporation, Medline Industries LP, Stryker Inc., Essity AB, Sonoma Pharmaceuticals Inc., B Braun Melsungen AG, Coloplast Corporation, ConvaTec Inc., Integra Lifesciences Corporation, Smith & Nephew, GOJO Industries, Hollister Inc., Welland Medical Ltd., DermaRite Industries LLC, Marlen Manufacturing & Development Co., Nu-Hope Laboratories Inc., Torbot Group Inc., EltaMD Inc., Rhode skin, Safe N Simple LLC, Cymed MicroSkin, Avène USA, Stratia Inc., KraveBeauty Inc., Cocokind.

North America was the largest region in the skin barrier market in 2024. The regions covered in the skin barrier market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the skin barrier market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The skin barrier is a vital component of the skin, functioning as a protective shield against external environmental factors, pathogens, and moisture loss. It plays a crucial role in controlling the outward flow of water, preserving moisture, and ensuring proper hydration. Comprising dead cells, lipids, proteins, and fats, the skin barrier effectively safeguards the skin from the surrounding environment.

The main types of skin barrier products include skin barrier sprays, moisture barrier creams, protective ointments, and others. Skin barrier sprays are topical products specifically designed to create a protective layer on the skin's surface. These products, available in both convex and flat shapes, serve various purposes, including addressing conditions such as incontinence and ostomy, chronic wounds, pressure ulcers, skin rashes and dry skin, and atopic dermatitis. They are distributed through various channels, including institutional sales and retail sales.

The skin barrier market research report is one of a series of new reports that provides skin barrier market statistics, including skin barrier industry global market size, regional shares, competitors with a skin barrier market share, detailed skin barrier market segments, market trends and opportunities, and any further data you may need to thrive in the skin barrier industry. This skin barrier market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The skin barrier market consists of sales of serums, cleansers, overnight masks, and creams. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.